Clinical trials sponsored by Xencor, Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Xencor, Inc.

• A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
  NCT07284797 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
  NCT07230353 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
  NCT06619990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 98 locations
• Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
  NCT05433142 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 26 locations

Common questions

How many trials is Xencor, Inc. recruiting for?

Xencor, Inc. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.